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Recognition by viral and cellular DNA polymerases of
nucleosides bearing bases with nonstandard hydrogen bonding
patterns
Abstract
The ability of DNA polymerases (pols) to catalyze the template-directed synthesis of duplex
oligonucleotides containing a nonstandard Watson-Crick base pair between a nucleotide bearing a
5-(2,4-diaminopyrimidine) heterocycle (d kappa) and a nucleotide bearing either deoxyxanthosine (dX)
or N1-methyloxoformycin B (pi) has been investigated. The kappa-X and kappa-pi base pairs are jointed
by a hydrogen bonding pattern different from and exclusive of those joining the AT and GC base pairs.
Reverse transcriptase from human immunodeficiency virus type 1 (HIV-1) incorporates dXTP into an
oligonucleotide opposite d kappa in a template with good fidelity. With lower efficiency and fidelity,
HIV-1 reverse transcriptase also incorporates d kappa TP opposite dX in the template. With d pi in the
template, no incorporation of d kappa TP was observed with HIV reverse transcriptase. The Klenow
fragment of DNA pol I from Escherichia coli does not incorporate d kappa TP opposite dX in a template
but does incorporate dXTP opposite d kappa. Bovine DNA pols alpha, beta, and epsilon accept neither
dXTP opposite d kappa nor d kappa TP opposite d pi. DNA pols alpha and epsilon (but not beta)
incorporate d kappa TP opposite dX in a template but discontinue elongation after incorporating a single
additional base. These results are discussed in light of the crystal structure for pol beta and general
considerations of how polymerases must interact with an incoming base pair to faithfully copy genetic
information.
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ABSTRACT The ability of DNA polymerases (pols) to
catalyze the template-directed synthesis of duplex oligonucle-
otides containing a nonstandard Watson-Crick base pair
between a nucleotide bearing a 5-(2,4-diaminopyrimidine)
heterocycle (dKc) and a nucleotide bearing either deoxyxan-
thosine (dX) or N'-methyloxoformycin B (w) has been inves-
tigated. The K-X and IC-T base pairs are joined by a hydrogen
bonding pattern different from and exclusive of those joining
the AT and GC base pairs. Reverse transcriptase from human
immunodeficiency virus type 1 (HIV-1) incorporates dXTP
into an oligonucleotide opposite dc in a template with good
fidelity. With lower efficiency and fidelity, HIV-1 reverse
transcriptase also incorporates d#cTP opposite dX in the
template. With dI in the template, no incorporation of dicTP
was observed with HIV reverse transcriptase. The Klenow
fragment of DNA pol I from Escherichia coli does not incor-
porate d#cTP opposite dX in a template but does incorporate
dXTP opposite dKc. Bovine DNA pols a, 1, and c accept neither
dXTP opposite dK< nor dKTP opposite dI. DNA pols a and E
(but not .8) incorporate d#cTP opposite dX in a template but
discontinue elongation after incorporating a single additional
base. These results are discussed in light of the crystal
structure for pol 13 and general considerations of how poly-
merases must interact with an incoming base pair to faithfully
copy genetic information.
Recognition between base pairs in complementary oligonu-
cleotide strands is mediated by two rules of complementarity:
size complementarity (large purines pair with small pyrimi-
dines) and hydrogen bonding complementarity (hydrogen
bond donors are matched with acceptors). Hydrophobicity and
planarity in the bases are also believed to be important for the
stability of the double helical structure. Hydrophobicity allows
transfer of the bases from water to the core of the double helix
to make an energetic contribution to duplex formation. Pla-
narity allows sequence-independent stacking of the bases to
form an aperiodic crystalline structure necessary for duplex
stability.
Even with these constraints, considerable structural flexi-
bility remains within the Watson-Crick base pair. For example,
Rich (1) pointed out in 1962 that isocytosine, which presents
a hydrogen bond acceptor-acceptor-donor pattern to the
complementary strand, might fit the Watson-Crick geometry
when paired with isoguanine (Fig. 1).t Zubay (2) proposed a
base pair joined by a nonstandard hydrogen bonding pattern,
although in a ring system that was not planar and therefore
presumably not able to stack.
Some time ago, we noted (3) that the Watson-Crick for-
malism could readily be extended to include 12 independently
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FIG. 1. Six base pairs that meet the constraints imposed by the
Watson-Crick base pairing geometry.
replicatable bases joined in 6 base pairs by mutually indepen-
dent hydrogen bonding patterns, provided that some bases
were joined to the sugar via a carbon-carbon bond (a "C
glycoside") (Fig. 1). We then asked whether natural DNA and
RNA polymerases (pols) could catalyze the template-directed
incorporation of these pairs into duplex DNA. If so, this could
increase the number of amino acids that might be encoded by
a mRNA (4), provide nonstandard sequence "tags" on oligo-
nucleotides used in diagnostic applications, expand the versa-
tility of experiments for the in vitro evolution of nucleic acids
(5-7), and assist efforts to obtain self-replicating oligonucle-
otides as models for the origin of life (3).
Previous work has shown that pols can accept the isocy-
tosine-isoguanine base pair (8-10), where both the purine and
the pyrimidine analogs are joined to the sugar ring by a
carbon-nitrogen bond. The Klenow fragment of DNA pol I
also incorporates deoxyxanthosine (dX) (11), a purine pre-
senting a hydrogen bond acceptor-donor-acceptor pattern to
a complementary strand, opposite 2,4-diamino-5-(13-D-2'-
deoxyribofuranosyl)pyrimidine (dK), a pyrimidine presenting
Abbreviations: pol, DNA or RNA polymerase; HIV-I, human immu-
nodeficiency virus type 1; BSA, bovine serum albumin; DTT, dithio-
threitol; M, marker; P, primer.
tIn dK, the heterocycle is joined to the sugar via a C-C bond. A crystal
structure of ribo-K as a hydrochloride (not shown) (49) shows that the
sugar ring of ribo-K exists in a pronounced C2'-endo conformation,
as in DNA. This suggests that the C-C bond need not by itself
exclude dK as a substrate; other studies suggest that C-glycoside
linkages need not be intrinsically problematic for a pol (12).
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the complementary donor-acceptor-donor hydrogen bonding
pattern. However, pots that accept triphosphates of C glyco-
sides have proven difficult to find. Recent work in these
(11-13) and other (14) laboratories has suggested that C
nucleosides might generally form weaker base pairs and might
be generally poor substrates for pots. We therefore undertook
a more systematic study of the enzymology of base pairing
between 2,4-diamino-5-(13-D-2'-deoxyribofuranosyl)pyrimidine
(dK, a C glycoside) and either deoxyxanthosine (dX) or 2'-deoxy-
1-methyloxoformycin B (dir) (Fig. 1), focusing on viral and
cellular DNA pots (15).
EXPERIMENTAL
Synthesis of Nucleosides Bearing Nonstandard Bases. N'-
Methyloxoformycin B (i7r) was prepared by the procedure of
Ugakar et at (16). 2,4-Diamino-5-(13-D-ribofuranosyl)pyrimi-
dine (K) was synthesized by the route of Chu et at (17). These
were converted to 2'-deoxygenated nucleoside analogs as
described by Piccirilli (18) and to 5'-dimethoxytritylated f3-cya-
noethyl phosphoramidites by standard methods (19). 5'-
Dimethoxytrityl-2'-deoxyxanthosine with both heterocyclic
ring oxygens protected as p-nitrophenylethyl ethers was pre-
pared following Van Aerschot et aL (20) and converted to the
phosphoramidite. The triphosphates dKTP and dXTP were
prepared following literature procedures (21, 22). Standard
dNTPs were from Pharmacia. Oligonucleotides were prepared
by solid-phase synthesis (Applied Biosystems) from 13-cyano-
ethyl-protected phosphoramidites, purified by the "trityl on"
procedure, deprotected, and purified again by HPLC (23).
Primer (18 bases, 5'-TAATACGACTCACTATAG-3') was
labeled at the 5' end with [-y_33P]ATP (Amersham) using T4
polynucle*itide kinase (24).
Enzymes, Proteins, and Chemicals. Human immunodefi-
ciency type 1 (HIV-1) reverse transcriptase overexpressed
using the plasmid pJS3.7 in Escherichia coli was purified by a
published procedure (25). Calf thymus DNA pots a, /3, and s
were purified according to the methods of Podust et al (26),
Chang (27), and Weiser et at (28), respectively. The Klenow
fragment of pot I (sequencing grade) was from Boehringer
Mannheim. DNase-free bovine serum albumin (BSA) was
from New England Biolabs. Other reagents were of analytical
grade from Fluka, Merck, or Aldrich.
Nucleic Acids. The template (5'-AGCCQGGCGCTAT-
AGTGAGTCGTATTA, 27 bases, Q is a nonstandard nudle-
otide) was annealed with primer in 750 jil of total buffer [50
pmol of template and 15 pmot of labeled primer, in 1.8 mM
Tris-HCI (pH 7), containing 0.5 MM MgCl2 and 23 mM NaCI]
by cooling from 750C to the assay temperature over a period
of 1 hr.
DNA Pol Assays. Pot assays were performed in a final
volume of 20 Al containing the following: for pot a, 20 mM
potassium phosphate (pH 7.2), 0.1 mM EDTA, 4 mM dithio-
threitol (DTT), 0.25 mg of BSA per ml, and 10 MM MgCt2; for
pot 3, 40 mM Tris-HCI (pH 7.5), 1 mM DTT, 0.2 mg of BSA
per ml, and 10 MM MgCl2; for pot E, 20 mM Tris (pH 7.2), 0.5
mM DTT, 0.1 mg of BSA per ml, 10 MM MgCl2, and 10 mM
MgCt2; for HIV-1 reverse transcriptase, 50 mM Tris-HCI (pH
7.2), 5 MM MgCI2, 80 mM KCI, 1 mM DTT, and 0.5 mM
EDTA; for Klenow fragment of pot I, 50 mM Tris-HCI (pH
7.5), 10 MM MgCt2, 0.1 mg of BSA per ml, and 1 mM DTT.
The amount of enzyme used and the concentrations of tem-
plates, primers, and nucleoside triphosphates are specified in
the figure legends. One unit of pot is defined as the amount of
enzyme that incorporates 1 nmot of total dNTP per hour at
370C.
The reactions were quenched by adding a formamide (3-5
gl) containing xylene cyanot (0.3%), bromphenol blue (0.3%),
and EDTA (0.37%), the samples were heated for 10 min at
750C, and aliquots (3-5 gl) were loaded onto a 13% polyacryl-
amide gel (16 cm X 42 cm X 0.6 mm) containing 7 M urea.
Following electrophoresis (50'C at 1500-1800 V), the gets
were fixed, dried,. and autoradiographed.
RESULTS
Klenow Fragment of DNA Pol I from E. coli. When the
Klenow fragment of pot I was incubated at 230C with templates
containing the nonstandard bases using enough pot to elongate
alt of the primer in 20 min, no incorporation of either dKTP or
dXTP opposite to its counterpart in a template could be
detected (Fig. 2a). Elongation of the primer stops just before
incorporation opposite the nonstandard base. With a 40-fold
a
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FIG. 2. Primer extension by the Klenow fragment of DNA pol I
from E. coli. Triphosphates present are indicated below. M indicates
markers (primer, full-length product). (a) Deoxynucleoside triphos-
phates (2 .tLM; 50 ttM when indicated by *) incubated at 230C for 20
min with primer/template (as 3'-OH primer end, 0.12 pmol) and 0.15
unit of the Klenow fragment of pollI in a final volume of 20 pil. (b) As
in a but with 0.8 unit of the Klenow fragment of pot I and incubation
for 30 min (c) As in a but with 6.0 units of the Klenow fragment of
pollI and incubation for 30 min.
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increase in pol concentration, no incorporation of dKTP was
observed opposite it in the template (Fig. 2c); nor could
convincing evidence be found for the incorporation of dKTP
opposite dX. In both cases, incorporation of dKTP and further
elongation were observed, but control experiments suggested
that these might reflect misincorporation of a standard base
opposite dX. An additional band (Fig. 2c) obtained with very
high concentrations of dKTP and enzyme suggested that dKTP
might be very inefficiently incorporated.
The Klenow fragment did, however, incorporate dXTP
opposite dK in a template with increasing enzyme concentra-
tions (Fig. 2 a-c), and increasing dXTP concentrations (to 50
,tM). Incorporation of dXTP is selective, as similar elongation
was not observed in the absence of dXTP with the four
standard bases. A substantial amount of product missing the
final base was also observed. This is frequently seen with fill-in
experiments using the Klenow fragment. These results confirm
and extend results obtained by Piccirilli et at (11).
HIV-1 Reverse Transcriptase. HIV-1 reverse transcriptase
incorporated dXTP opposite dK in a template at low concen-
trations of enzyme and low concentrations of dXTP (Fig. 3a).
A product with a single base incorporated opposite dK and a
smaller amount of fully extendible product were seen. No
misincorporation of the standard dNTPs could be detected
under similar conditions. At 25-fold higher concentrations of
dXTP, primer elongated by addition of dXTP was the major
product, with substantial amounts of full-length product also
observed. Higher concentrations of standard dNTPs yielded
only a trace of misincorporation. Thus, HIV-1 reverse tran-
scriptase incorporates dXTP opposite dK in a template with
a
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FIG. 3. Primer extension by HIV-1 reverse transcriptase. Triphos-
phates present are indicated below. (a) Deoxynucleoside triphosphates
(2 ,uM; 50 ,uM when indicated by *) incubated at 37°C for 30 min with
primer/template (as 3'-OH primer end, 0.13 pmol) and 0.12 unit of
HIV-1 reverse transcriptase in a final volume of 20 ,ul. (b) De-
oxynucleoside triphosphates (2 ,uM; 25 ,uM when indicated by *)
incubated at 37°C for 45 min with primer/template (as 3'-OH primer
end, 0.08 pmol) and 0.37 unit of HIV-1 reverse transcriptase in a total
volume of 20 ,lI.
good yields and high selectivity. However, the pol still clearly
recognizes dXTP as foreign, as considerable chain termination
occurred immediately before incorporation of dXTP and, at
concentrations of dXTP where pausing is eliminated, after
incorporation of the dX-dK base pair into the duplex product.
With templates containing dX, a small amount of fully
extended product is observed at low concentrations (2 ,uM) of
dKTP. Substantial amounts of full-length product are observed
at 50 ,uM dKTP when the standard dNTPs remained at low
concentration (2 ,uM). Misincorporation of the standard
dNTPs (50 ,uM) also yielded full-length products (Fig. 3).
Thus, the discrimination between dK and the standard dNTPs
opposite dX in a template is not particularly good. However,
it is interesting to note that HIV-1 reverse transcriptase does
not pause significantly after incorporation of dKTP opposite
dX in the template, in contrast to the pause observed after the
incorporation of dXTP opposite dK. Thus, although dKTP is
incorporated with lower selectivity than dXTP by HIV-1
reverse transcriptase, it is incorporated with higher overall
efficiency.
Experiments at higher concentrations of enzyme showed the
selectivity of incorporation of dXTP opposite dK in the
template. With dGTP and dCTP alone, primer extension stops
just before the dK in the template without substantial misin-
corporation. Further, neither dT nor dA was misincorporated
in the absence of dX at 2 ,uM. Even at high (25 ,uM)
concentrations of each of the four standard dNTPs, only a
trace of full-length product was observed.
CalfThymus DNA Pols a, fB, and c. These three pols all did not
incorporate dXTP opposite dK in a template (Fig. 4 b and d).
Furthermore, no misincorporation was observed. Similarly, nei-
ther incorporation of dKTP nor misincorporation was observed
opposite iT (Fig. 4a). With templates containing dX, the pols
behaved differently. No incorporation of dKTP was detectable
with pol ,B, even at 50 ,uM concentrations. Pol a incorporated
dKTP opposite dX in a template (Fig. 4c). Primer extension stops,
however, after incorporation of a single additional base following
dK, with substantial amounts of pausing. In the presence ofdCTP
and dGTP alone with pol a, primer extension was terminated at
the nonstandard base. A small but significant amount of misin-
corporation opposite dX was observed only at high concentra-
tions of standard dNTPs (50 ,uM each). With pol s (29-32), a
similar but not identical behavior was observed (Fig. 4d). Incu-
bation in the presence of dKTP, dCFP, and dGTP showed
incorporation of a base opposite dX in the template and contin-
ued elongation by only a single additional base. Unlike with pol
a, however, less pausing was observed after dKTP was incorpo-
rated. The amount of dK incorporated increased at higher con-
centrations of dKTP.
DISCUSSION
The ability of pols to accept the dK-dX nonstandard base pair
is remarkably variable, especially considering that all pols
appear to be homologous (judging by the common three-
dimensional fold in those studied). In some cases, dKTP was
not incorporated. In others, difficulties in polymerization were
encountered only after the incorporation of dKTP, as if the pol
rejected dK in the primer. dXTP was easily incorporated by
some polymerases and firmly rejected by others. During the
divergent evolution of the polymerase superfamily, features in
the active site that make contact with the bases in the template,
primer, and triphosphate must have diverged considerably, and
these interactions (rather than an intrinsic property of the
nonstandard nucleosides themselves) must be the primary
determinant of the outcome of a replication experiment with
a nonstandard base.
The ability of pols to accept a nonstandard base does not
correlate cleanly with overall specificity. Pol ,B is the least
selective of the pols examined here. Indeed, pol 13 is so efficient
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at incorporating mismatches into duplex DNA that early
speculation suggested that it required no template (33), a
speculation reinforced by its homology with terminal de-
oxynucleotidyltransferase. Yet pol is extremely discriminat-
ing with the nonstandard dK-dX base pair. This discrimination
cannot be explained by proofreading (34-36), as pol X3 does not
have a proofreading 3' -> 5' exonuclease activity. The dis-
crimination must occur during the elongation reaction itself.
Direct contacts between the bases and the side chains of
residues in pol ,B may be invoked to explain the extreme
specificity of the enzyme. Pelletier et at (37) report that
Lys-234 in pol ,B forms a hydrogen bond to the lone pair of
electrons on oxygen-2 of a cytosine in the template, Tyr-271
forms a hydrogen bond to the 0-2 lone pair of a cytosine in the
primer, and Arg-283 forms a hydrogen bond to a lone pair on N-4
of a guanine in the template. These lone pairs of electrons are
significant, as they are the only structural feature presented in
common to the grooves of duplexDNA by all four base pairs (AT,
TA, GC, and CG). This lone pair is replaced by an N-H bond
in both dK and dX. While Tyr-271 might be ambivalent (accepting
both hydrogen bond donor and acceptor groups) at this position
in the oligonucleotide, neither Lys-234 nor Arg-283 should tol-
erate this replacement. Accordingly, site-directed mutagenesis
experiments targeted against these two residues might yield
mutant forms of pol ,B that accept dK and dX.
Crystal structures for other pols are available (38-40), but
without a full complement of bound substrates. Thus, specific
residue-substrate interactions that might explain specificity in
these enzymes are difficult to assign, especially as conforma-
tional changes evidently occur upon formation of the active
complex (41-44). For these pols, site-directed mutagenesis
(45, 46) should, in combination with studies using nonstandard
bases, prove valuable in interpreting crystallographic informa-
tion regarding these interactions.
The idiosyncracies displayed by pols are also surprising in light
of the physiological role that a pol must play. Pols must faithfully
convert information in a template strand (DNA or RNA) into
Ftc. 4. Primer extension by calf thymus DNA pols aY, 3, and Triphos-
hates presenit are indicated below. (fi) Deoxynucleoside triphosphatcs (2 FM:
5 jM whcn indicated by 100;I()()M wheni indicated by when pol a was
sted; I (,uM; 25 ,uM when indicatcd by I00 AM whctn indicated by whiell
ol wcas tested) incubated at 370C for 30 min with prinicr/template
tntain ing r (as 3'-OH primer cnd, (). 17 pmol when polrw stested; 0.15 pmol
hen pol was tested). The amounts of pol oa and pol B tcsted in a final volume
20 Al were 0.24 unit and 6.6 uniits, respectively. (b) As in ta but with a
mplite/pr-inmrer(ntaininigdK. (c ) De)oxynucleoside triphosphaltes (2 uM 5t()
.M when indicated by when pol (x was tested: I ,M; 5t0 MM when indicated
y* when pol was tested) incuibated at 37C {or 30 min with primcr/tcmplate
a)nttaining X (as 3-OH primcr cnd, 0.15 pnmol) and either- pol cy (0.16 unit)
r pol [3 (4.4 units) in a final volumc of 20 M1l. (cl) Deoxynucleoside
*iphosphates (2 AM: 50 AM when indicated by ) incubated with pol aE (0.007
nit) at 37TC for 30 min withi primer/template (as 3-Ol-1 primcr end, t).16
nmol) in a final volume of 20 M'.
information in a product (DNA or RNA). The pol must choose
the appropriate sugar, enforce a Watson-Crick geometry (as
opposed to a wobble geometry, for example) (47), and provide
most of the selective binding to the pentacoordinated phosphate
in the transition state to catalyze the reaction. However, the
template, not the pol, should choose the pattern of hydrogen bond
donor and acceptor groups in the incoming base once the
Watson-Crick geometry is imposed. Any preference that a pol
itself might have for one of the four natural base pairs would
decrease its overall efficiency and fidelity.
In this view, the pol should make contacts with the bases at
only those positions where the standard bases have similar
structural features, for example, with the lone pairs of elec-
trons on 0-2 of pyrimidines and N-3 of purines. The crystal
structure of pol , suggests that these contacts, and no others,
are made between the enzyme and the bases (37).
This view cannot, however, be general. The Klenow frag-
ment accepts X as a triphosphate and K as a template. Both
replace the common lone pair (0-2 of pyrimidines, N-3 of
purines) by an NH group. It is hard to see what Klenow might be
identifying that allows it to discriminate against dK (but not dX)
as a triphosphate, or against dX (but not dK) in the template,
without creating an interaction that will disrupt the neutrality of
the pol with respect to the four standard base pairs. This becomes
doubly problematic in light of recent results that show that
Klenow accepts isocytosine in the template and as a triphosphate,
although with some bias against isocytosine (8). Klenow cannot
be searching rigorously for the 0-2 lone pair (for pyrimidines) or
the N-3 lone pair (for purines).
A final point must be made concerning HIV-1 reverse tran-
scriptase, which accepts a wide range of substrates, including
nucleoside triphosphates modified on the sugar (48). There is no
reason a priori why tolerance of modified sugars should fore-
shadow tolerance of nonstandard base pairs. That HIV tolerates
variation in both is consistent, however, with the common view
that the active site in HIV-1 reverse transcriptase is "looser" than
Polyvicrase:
ProduLct
sc(tience:
27T
26 C
25 G
24 G
23K
22 Cr
21 C
20 G
19C
Primer '
Proc. Natl. Acad. Sci. USA 92 (1995)
F
.N..M.
N.
K- K*
A*k
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in other pols. The implications of this for the design of inhibitors
for HIV reverse transcriptase are evident.
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